Regen BioPharma initiates NR2F6 T-cell immunotherapy preclinical studies
12 November 2015 | By Victoria White
The studies will evaluate the utilisation of NR2F6 gene silencing as a means of stimulating the immune system in cancer patients...
List view / Grid view
News
Enterome and Gustave Roussy in microbiome collaboration
12 November 2015 | By Victoria White
The collaboration’s ambitious objective is to develop a new generation of drugs and non-invasive monitoring tools of the gut microbiome in immuno-oncology...
Study finds levodopa delays onset of macular degeneration
11 November 2015 | By Victoria White
Scientists found that patients who began taking levodopa before they developed macular degeneration were diagnosed with the eye disease eight years later than those who had never taken the treatment...
Boehringer Ingelheim pledges EUR 11 billion to R&D
11 November 2015 | By Victoria White
Of the total investment, EUR 5 billion will go to preclinical R&D with EUR 1.5 billion thereof planned for collaborations with external partners...
GeneOne Life Science and WRAIR to develop MERS vaccine
11 November 2015 | By Victoria White
Earlier this year, GLS-5300 induced 100% protection from a live MERS virus challenge in a preclinical animal study...
Studies justify mode of delivery and dosing regimen for Anisina
11 November 2015 | By Victoria White
Preclinical studies confirm the efficacy of Anisina when delivered using a clinically relevant formulation, mode of administration and dosing regimen...
Scientists help launch human dark proteome initiative
10 November 2015 | By Victoria White
The initiative aims to accelerate research into biology's "invisible mass" to provide novel insights into cell function and a new frontier in drug discovery...
Scientists use dead C. sporogenes bacteria to kill cancer cells
10 November 2015 | By Victoria White
In a 72-hour experiment, the inactive bacteria were able to reduce the growth of colon tumour cells by 74%...
E12-7Fc-M3 demonstrates efficacy as treatment for cocaine overdose
10 November 2015 | By Victoria White
E12-7Fc-M3 not only demonstrated a significantly improved efficiency against cocaine, but also had a considerably prolonged biological half-life in animal models...
Cholesterol-lowering vaccine shows promise in preclinical studies
10 November 2015 | By Victoria White
Scientists from the University of New Mexico and NIH have created a cholesterol-lowering vaccine that leads to reductions in LDL cholesterol in mice and macaques...
Boehringer Ingelheim announces IBD research collaborations
10 November 2015 | By Victoria White
The collaborations aim to identify and validate potential new therapeutic targets as well as identify biomarkers...
Pharnext’s PXT-864 shows promise in Parkinson’s disease
10 November 2015 | By Victoria White
In preclinical studies, researchers showed that PXT-864, a combination of baclofen and acamprosate, improved multiple endpoints associated with the development and progression of Parkinson's disease...
Sanofi Pasteur reveals universal flu vaccine research
10 November 2015 | By Victoria White
Sanofi Pasteur's experimental vaccine is a novel synthetic vaccine generated from key genetic sequences of many flu viruses...
Scientists discover genetic cause and mechanism of noise-induced hearing loss
6 November 2015 | By Victoria White
The absence of pejvakin appears to be responsible for noise-induced hearing loss, one of the most common causes of deafness...
Global and USA Biosimilar Market: Updates from Hospira, Sandoz, Merck, Teva, Boehringer Ingelheim
6 November 2015 | By SMi
Leading organizations in the Biosimilars Development sector will meet at Biosimilars and Biobetters USA 2015 – the must-attend premier industry event which will take place in Iselin this November...